Audit Readiness Resources for Pharmaceutical Manufacturing
Checklists, investigator profiles, and regulatory intelligence built by compliance experts — helping your team prepare for FDA inspections, understand who's coming, and close gaps before they become observations.
These checklists aren't static templates
They're shaped by live FDA enforcement data — 483 trends, warning letter patterns, and inspection focus areas — continuously analysed by our AI-powered regulatory intelligence platform.
These checklists aren't static templates
They're shaped by live FDA enforcement data — 483 trends, warning letter patterns, and inspection focus areas — continuously analysed by our AI-powered regulatory intelligence platform.
Explore FDA TrackerInspection Framework
Organised around the FDA's Six Systems Inspection Model
FDA investigators don't audit randomly. Every inspection follows the Compliance Program Guidance Manual's six-system framework — evaluating your operation across Quality, Production, Facilities & Equipment, Laboratory Controls, Materials, and Packaging & Labeling.
Our checklists mirror this structure so your team can self-assess exactly the way an investigator would, system by system, before they arrive on site.
Quality System
Management oversight, CAPA, complaints, change control, annual product reviews, and the overall quality unit responsibilities that govern every other system.
Production System
Batch record review, in-process controls, process validation, charge-in verification, and manufacturing operations that transform raw materials into finished product.
Facilities & Equipment System
Facility design, HVAC qualification, equipment calibration, preventive maintenance, cleaning validation, and environmental controls.
Laboratory Controls System
Analytical method validation, OOS/OOT investigations, stability programmes, reference standards, and data integrity across chromatographic and wet-chemistry systems.
Materials System
Supplier qualification, incoming material testing, storage conditions, inventory controls, rejection/disposition procedures, and supply chain traceability.
Packaging & Labeling System
Label control and reconciliation, packaging line clearance, tamper-evident features, serialisation, and post-packaging inspection procedures.
Audit Readiness Resources
Complaint Management Audit Readiness
End-to-end audit readiness checklist for pharmaceutical complaint management systems, covering complaint investigation thoroughness, root cause analysis, retain sample testing, CAPA linkage, and trending analysis aligned with FDA 483 focus areas.
CAPA Management Audit Readiness
Audit readiness checklist for CAPA systems covering initiation timeliness, root cause analysis quality, effectiveness checks, recurrence prevention, and management review integration — built from real FDA 483 observation patterns.
Quality Risk Management Audit Readiness (ICH Q9)
Comprehensive 100-point QRM audit checklist spanning all six FDA systems plus documentation, training, complaint management, and continuous improvement — structured as Yes/No/NA self-assessment questions aligned with ICH Q9 and ICH Q10.
Document Management Audit Readiness
Comprehensive 150+ point audit checklist for pharmaceutical document management covering SOP governance, controlled document issuance, training and competency, QA oversight, data integrity and GDP compliance, retention and archiving, manufacturing and QC records, and policy governance.
Quality Investigations Audit Readiness
End-to-end audit checklist for pharmaceutical investigation systems covering investigation governance, deviation and RCA processes, OOS/OOT management, environmental excursion and contamination investigations, complaint and adverse event handling, CAPA effectiveness, and quality trending.
Deviation Management Audit Readiness
Audit readiness checklist for pharmaceutical deviation management covering documentation procedures, root cause analysis, CAPA linkage, regulatory compliance, equipment and facility deviations, communication protocols, and post-implementation monitoring.
Change Control Audit Readiness
Audit readiness checklist for pharmaceutical change control systems covering documentation procedures, impact analysis, risk assessments, regulatory compliance, equipment and facility changes, communication protocols, and post-implementation monitoring.
Batch Record Review & Disposition Audit Readiness
Comprehensive 140+ point audit checklist for pharmaceutical batch production record management covering master batch record control, contemporaneous documentation and GDP compliance, in-process controls and yield calculations, Quality Unit production record review, equipment documentation, labeling and reconciliation, training, electronic systems and data integrity, and trending — grounded in real FDA 483 observation patterns under 21 CFR 211.188 and 211.192.
Process Validation Lifecycle Audit Readiness
Comprehensive 150+ point audit checklist for pharmaceutical process validation covering the FDA three-stage lifecycle model — Process Design (Stage 1), Process Qualification (Stage 2), and Continued Process Verification (Stage 3) — plus revalidation triggers, in-process controls, microbiological contamination controls, and validation documentation aligned with the FDA 2011 Process Validation Guidance and 21 CFR 211.100/211.110.
Audit Management Audit Readiness
Audit readiness checklist for pharmaceutical audit management covering audit procedures and scheduling, audit planning and execution, findings documentation and root cause analysis, regulatory compliance, facility and equipment inspections, communication protocols, and post-audit monitoring.
OOS/OOT Investigation Procedures Audit Readiness
Comprehensive 130+ point audit checklist for pharmaceutical OOS and OOT investigation procedures covering investigation governance, Phase I laboratory assessment, Phase II full-scale investigation, retesting and resampling rules, out-of-trend detection and escalation, batch disposition, chromatographic data integrity, and CAPA effectiveness — grounded in real FDA 483 observation patterns under 21 CFR 211.192 and the FDA OOS Guidance for Industry.
In-Process Controls & Sampling Audit Readiness
Comprehensive 160-point audit checklist for pharmaceutical in-process controls covering CPP identification and control strategy, sampling plan design and statistical rationale, in-process testing methods and acceptance criteria, hold time validation, Quality Unit oversight, and trend analysis — grounded in real FDA 483 observation patterns under 21 CFR 211.110 and 21 CFR 211.100.
Equipment Cleaning Validation Audit Readiness
Comprehensive 140-point audit checklist for pharmaceutical equipment cleaning validation covering HBEL/MACO acceptance limit determination, worst-case equipment and product grouping, cleaning SOP adequacy, swab and rinse sampling strategy, analytical method validation, dirty and clean hold time studies, and lifecycle change control — grounded in real FDA 483 observation patterns under 21 CFR 211.67 and the EMA HBEL Guideline.
Line Clearance & Contamination Control Audit Readiness
Comprehensive 153-point audit checklist for pharmaceutical line clearance and contamination control covering contamination control strategy documentation, pre-production line clearance procedures, facility segregation and material flow, environmental monitoring programme design, cleaning and sanitization for contamination control, multi-product campaign changeover controls, and QA oversight — grounded in real FDA 483 observation patterns under 21 CFR 211.42 and 21 CFR 211.113.
Leucine is the first AI-native platform built for pharmaceutical manufacturing. It unifies quality management, regulatory compliance, and production operations into one intelligent system that powers your entire drug manufacturing lifecycle from raw materials to patient delivery.
